Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$5.7M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 8 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 12 most recent Form 4 transactions.
| Open the original filing on SEC.gov |
| Mar 4 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 2,437 | $475.30 | $1.2M | -13.9% | Open the original filing on SEC.gov |
| Feb 25 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 2,410 | $489.00 | $1.2M | -12.1% | Open the original filing on SEC.gov |
| Feb 25 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 2,500 | $486.35 | $1.2M | -11.1% | Open the original filing on SEC.gov |
| Feb 24 | VRTX | Vertex Pharmaceuticals… | FTAX◷ | 873 | $485.11 | $423.5K | -3.7% | Open the original filing on SEC.gov |
| Feb 17 | VRTX | Vertex Pharmaceuticals… | FTAX | 1,148 | $483.75 | $555.3K | -4.7% | Open the original filing on SEC.gov |
| Feb 17 | VRTX | Vertex Pharmaceuticals… | AGRANT | 4,962 | — | — | +25.4% | Open the original filing on SEC.gov |
| Feb 13 | VRTX | Vertex Pharmaceuticals… | FTAX | 2,283 | $487.76 | $1.1M | -10.5% | Open the original filing on SEC.gov |
| Feb 10 | VRTX | Vertex Pharmaceuticals… | FTAX | 1,127 | $468.41 | $527.9K | -4.9% | Open the original filing on SEC.gov |
| Jan 22 | VRTX | Vertex Pharmaceuticals… | AGRANT | 2,080 | — | — | +10.0% | Open the original filing on SEC.gov |
| Jan 22 | VRTX | Vertex Pharmaceuticals… | AGRANT | 4,720 | — | — | +29.3% | Open the original filing on SEC.gov |